Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia

Summary

The primary objective of this study is to assess the ability of epoetin alfa to raise hemoglobin (Hb) levels in elderly outpatients with unexplained anemia. The secondary objectives of this study are to assess the ability of epoetin alfa to improve physical function; cognitive function; and quality of life, and to assess the safety of epoetin alfa in the study population.

Timeline

Start

2008-12

Primary completion

2011-02

Completion

2011-02

Outcome

Outcome not reported

Stopped: “Difficulty in identifying interested subjects.”

Drugs

Indications